Woburn, MA, 12 November 2026 – Curiox Biosystems Inc (Curiox) (KOSDAQ:445680), the innovator of centrifuge-free (C-FREE™) sample preparation technologies for reproducible, automated flow cytometry workflows, today announced that the Company filed a lawsuit against Becton, Dickinson and Company (BD) and Waters Corporation for trade secret misappropriation, breach of contract, and related claims in the United States District Court for the Northern District of California.
The lawsuit is based in part on the breach of an NDA signed between Curiox and BD’s Biosciences division, which was later acquired by Waters Corporation. The NDA prohibited BD Biociences from from using Curiox’s confidential information to develop a competing product, including by reverse engineering and unauthorized replication.
Curiox is seeking appropriate relief, including damages and injunctive relief to prevent further misuse of the technology the Company invented and commercialized. As the matter is now before the Court, Curiox does not intend to comment further at this time.
